Skip to content
Attgeno
Menu
Supernitro
About us
Management Team
Board of Directors
News
Contact & Info
2020, Feb
Clinical phase 1 FIH study approved by Swedish MPA
2020, Feb
←
New NO-donating substances
Second financial round oversubscribed rights issue
→
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
Ok